Cell type specificity of the human endoglin promoter

Gene

Volumn 227, Issue 1, 1999, Pages 55-62

  Graulich, Wolff ^a   Nettelbeck, Dirk M ^a   Fischer, Dagmar ^a   Kissel, Thomas ^a   Müller, Rolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Endoglin CD105 promoter; Endothelial cells; Tissue specific gene expression; Transcriptional regulation

Indexed keywords

ENDOGLIN;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL TYPE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD; CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; CLONING, MOLECULAR; GENE EXPRESSION; HELA CELLS; HUMANS; MICE; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA;

EID: 0033521865     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00585-X     Document Type: Article

References (27)

1. Almendro, N., Bellon, T., Rius, C., Lastres, P., Langa, C., Corbi, A., Bernabeu, C., 1996. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J. Immunol. 157, 5411-5421.
2. Ausubel, I., Frederick, M., 1991. In: Current Protocols in Molecular Biology. John Wiley, New York, NY.
3. Burrows, F.J., Thorpe, P.E., 1994. Vascular targeting - a new approach to the therapy of solid tumors. Pharmacol. Ther. 64, 155-174.
4. Caniggia, I., Taylor, C.V., Ritchie, J.W., Lye, S.J., Letarte, M., 1997. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138, 4977-4988.
5. Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massague, J., LeTarte, M., 1992. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 267, 19027-19030.
6. Derynck, R., Feng, X.H., 1997. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333, F105-F150.
7. Hamilton, T.C., Young, R.C., McKoy, W.M., Grotzinger, K.R., Green, J.A., Chu, E.W., Whang-Peng, J., Rogan, A.M., Green, W.R., Ozols, R.F., 1983. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43, 5370-5389.
8. Hohenwarter, O., Jakoubek, A., Schmatz, C., Katinger, H., 1994. Expression of SV40 tumour antigens enables human endothelial cells to grow independently from foetal calf serum and exogenous growth factors. J. Biotechnol. 34, 205-211.
9. Jaffe, E., 1986. In: Jaffe, E. (Ed.), Biology of Endothelial Cells. Martinus Nijhoff, Boston, pp. 1-13.
10. Jahroudi, N., Ardekani, A.M., Greenberger, J.S., 1996. An NF1-like protein functions as a repressor of the von Willebrand factor promoter. J. Biol. Chem. 271, 21413-21421.
11. Jahroudi, N., Lynch, D.C., 1994. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol. Cell. Biol. 14, 999-1008.
12. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S., Wang, J.M., 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25, 1794-1798.
13. Kumar, P., Wang, J.M., Bernabeu, C., 1996. CD105 and angiogenesis. J. Pathol. 178, 363-366.
14. Lastres, P., Letamendia, A., Zhang, H., Rius, C., Almendro, N., Raab, U., Lopez, L.A., Langa, C., Fabra, A., LeTarte, M., Bernabeu, C., 1996. Endoglin modulates cellular responses to TGF-beta 1. J. Cell Biol. 133, 1109-1121.
15. Letarte, M., Greaves, A., Vera, S., 1995. In: Schlossman, S.F. et al. (Eds.), Leukocyte Typing V. Oxford University Press, Oxford, pp. 1756-1759.
16. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J. et al., 1994. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345-351.
17. Patterson, C., Perrella, M.A., Hsieh, C.M., Yoshizumi, M., Lee, M.E., Haber, E., 1995. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270, 23111-23118.
18. Pece, N., Vera, S., Cymerman, U., White, R.I.J., Wrana, J.L., Letarte, M., 1997. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J. Clin. Invest. 100, 2568-2579.
19. Prestridge, D.S., 1991. SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements. Cabios 7, 203-206.
20. Quandt, K., Frech, K., Karas, H., Wingender, E., Werner, T., 1995. MatInd and MatInspector - new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884.
21. Rönicke, V., Risau, W., Breier, G., 1996. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ. Res. 79, 277-285.
22. Schlaeger, T., Bartunkova, S., Lawitts, J.A., Teichmann, G., Risau, W., Deutsch, U., Sato, T.N., 1997. Uniform vascular-endothelial-cell-specific gene expresion in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA 94, 3058-3063.
23. Smale, S.T., Baltimore, D., 1989. The 'initiator' as a transcription control element. Cell 57, 103-113.
24. Thornton, S.C., Mueller, S.N., Levine, E.M., 1983. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 222, 623-625.
25. Thorpe, P.E., Burrows, F.J., 1995. Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res. Treat. 36, 237-251.
26. van de Kerkhof, P.C., Rulo, H.F., van Pelt, J.P., van Vlijmen-Willems, I.M., De Jong, E.M., 1998. Expression of endoglin in the transition between psoriatic uninvolved and involved skin. Acta Derm. Venereol. 78, 19-21.
27. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., Massague, J., 1994. Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.